Researchers report they found that suppressing a single protein significantly extended the lives of mice with a form of ALS, according to a study at Stanford University.
A recent discovery in mice might one day lead to a new approach for treating people with amyotrophic lateral sclerosis, or ALS, researchers report.
They found that suppressing a single protein significantly extended the lives of mice with a form of ALS, a progressive neurodegenerative condition also known as Lou Gehrig's disease.
